Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 22988253)

1.

Intracellular and extracellular ATP coordinately regulate the inverse correlation between osteoclast survival and bone resorption.

Miyazaki T, Iwasawa M, Nakashima T, Mori S, Shigemoto K, Nakamura H, Katagiri H, Takayanagi H, Tanaka S.

J Biol Chem. 2012 Nov 2;287(45):37808-23. doi: 10.1074/jbc.M112.385369. Epub 2012 Sep 17.

2.

[Role of mitochondria in osteoclast function].

Miyazaki T.

Clin Calcium. 2013 Nov;23(11):1577-83. doi: CliCa131115771583. Review. Japanese.

PMID:
24162597
3.

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.

Valverde P, Tu Q, Chen J.

J Bone Miner Res. 2005 Sep;20(9):1669-79. Epub 2005 May 16.

PMID:
16059638
4.

RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.

Wu X, Pan G, McKenna MA, Zayzafoon M, Xiong WC, McDonald JM.

J Bone Miner Res. 2005 Jan;20(1):107-16. Epub 2004 Oct 25.

PMID:
15619676
5.

The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice.

Iwasawa M, Miyazaki T, Nagase Y, Akiyama T, Kadono Y, Nakamura M, Oshima Y, Yasui T, Matsumoto T, Nakamura T, Kato S, Hennighausen L, Nakamura K, Tanaka S.

J Clin Invest. 2009 Oct;119(10):3149-59. doi: 10.1172/JCI39819. Epub 2009 Sep 14.

6.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

PMID:
16059637
7.

Anti-apoptotic Bcl-2 family member Mcl-1 regulates cell viability and bone-resorbing activity of osteoclasts.

Masuda H, Hirose J, Omata Y, Tokuyama N, Yasui T, Kadono Y, Miyazaki T, Tanaka S.

Bone. 2014 Jan;58:1-10. doi: 10.1016/j.bone.2013.09.020. Epub 2013 Oct 2.

PMID:
24096094
8.

TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function.

Wu M, Wang Y, Deng L, Chen W, Li YP.

Int J Biol Sci. 2012;8(10):1398-407. doi: 10.7150/ijbs.5079. Epub 2012 Nov 6.

9.

The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.

Adapala NS, Barbe MF, Langdon WY, Nakamura MC, Tsygankov AY, Sanjay A.

J Biol Chem. 2010 Nov 19;285(47):36745-58. doi: 10.1074/jbc.M110.124628. Epub 2010 Sep 17.

10.

Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.

Korcok J, Raimundo LN, Ke HZ, Sims SM, Dixon SJ.

J Bone Miner Res. 2004 Apr;19(4):642-51. Epub 2004 Jan 5.

PMID:
15005852
11.

Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro.

Gartland A, Buckley KA, Bowler WB, Gallagher JA.

Calcif Tissue Int. 2003 Oct;73(4):361-9. Epub 2003 Jul 24.

PMID:
12874700
12.
13.

TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption.

Chamoux E, Bisson M, Payet MD, Roux S.

J Biol Chem. 2010 Aug 13;285(33):25354-62. doi: 10.1074/jbc.M109.075234. Epub 2010 Jun 11.

14.

Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.

Ha H, Shim KS, An H, Kim T, Ma JY.

BMC Complement Altern Med. 2013 May 21;13:112. doi: 10.1186/1472-6882-13-112.

15.

Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.

El Hajj Dib I, Gallet M, Mentaverri R, Sévenet N, Brazier M, Kamel S.

Eur J Pharmacol. 2006 Dec 3;551(1-3):27-33. Epub 2006 Sep 16.

PMID:
17049513
16.

Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts.

Komarova SV, Pereverzev A, Shum JW, Sims SM, Dixon SJ.

Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2643-8. Epub 2005 Feb 4.

17.

IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling.

Mangashetti LS, Khapli SM, Wani MR.

J Immunol. 2005 Jul 15;175(2):917-25.

18.

Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.

Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.

J Cell Physiol. 2009 Dec;221(3):618-28. doi: 10.1002/jcp.21892.

PMID:
19653230
19.

Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Okayasu M, Nakayachi M, Hayashida C, Ito J, Kaneda T, Masuhara M, Suda N, Sato T, Hakeda Y.

J Biol Chem. 2012 Jun 1;287(23):19229-41. doi: 10.1074/jbc.M111.323600. Epub 2012 Apr 12.

20.

Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.

Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.

J Cell Physiol. 2003 Jul;196(1):180-9.

PMID:
12767054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk